Are Changes in Thyroid Hormones Associated with Mortality in Non-Thyroidal Illness Syndrome?



Abstract Views
662

Downloads
208

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Dec 3, 2021
Published Dec 29, 2021
10.24018/clinicmed.2021.2.6.148

Abstract viewed = 662 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Introduction: Non-thyroidal illness syndrome (NTIS) can be defined as afunctional impairment of the hypothalamic-pituitary-thyroid axis accompanied by signs of non-thyroidal disease with changes in thyroid stimulating hormone (TSH), free T3 (fT3) and free T4 (fT4) levels. NTIS and thyroid hormone levels in this syndrome are thought to be related with mortality. This study was performed to evaluate the relationship between hormone levels and mortality in this syndrome.

Methods: The 5-year mortality data of patients who were hospitalized in the first 6 months of 2014 and whose thyroid hormone levels could be checked twice within 5 years were evaluated. In our study conducted with 405 patients whose thyroid function tests was repeated, the follow-up period was 5 years. Biochemical parameters including thyroid function tests were sent from all patients. NTIS was defined as a condition in patients with low fT3 levels (<2.5 pg/mL) and TSH levels within the normal range (0.38-5.33 mIU / L).

Results: 128 patients died, and the number of surviving patients was 277 during the follow-up period. Positive acute phase reactants such as CRP, sedimentation, ferritin was high and albumin (negative acute phase reactant) and fT3 levels were low in patients who died. In addition, these changes in biochemical values were statistically significant. The mortality rate was increased in patients with low fT3 and high fT4 levels. In the follow-up period, changes in TSH levels were not significantly associated with mortality.

Conclusion: Both the decrease in fT3 levels and the increase in fT4 levels can be used as predictors and independent risk factors for long-term mortality risk in chronically ill and hospitalized patients with NTIS.

Keywords: Mortality, non-thyroidal illness syndrome, serum free T3, serum free T4

References

  1. Lee S, Farwell AP. Euthyroid sick syndrome. Comprehensive Physiology. 2016; 6(2): 1071–80.
     Google Scholar
  2. Depuydt PO, Kress P, Salluh IF. The ten "diseases" that are not true diseases. Intensive Care Medicine. 2016; 42: 411-414.
     Google Scholar
  3. deVries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. The Journal of Endocrinology. 2015; 225(3): 67–81.
     Google Scholar
  4. Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. The Journal of Clinical Investigation. 2011; 121(5): 1834.
     Google Scholar
  5. Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin Endocrinol (Oxf). 2021; 00: 1–9.
     Google Scholar
  6. Hershman JM. Euthyroid Sick Syndrome: Thyroid Disorders. Merck Manual Professional. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.; 2009.
     Google Scholar
  7. Dickerman AL, Barnhill JW. Abnormal thyroid function tests in psychiatric patients: a red herring? Am J Psychiatry. 2012; 169(2): 127-33.
     Google Scholar
  8. Taroza S, Rastenytė D, Podlipskytė A, Kazlauskas H, Mickuvienė N. Nonthyroidal Illness Syndrome in Ischaemic Stroke Patients is Associated with Increased Mortality. Exp Clin Endocrinol Diabetes. 2020; 128(12): 811-818.
     Google Scholar
  9. Padhi R, Kabi S, Panda BN, Jagati S. Prognostic significance of nonthyroidal illness syndrome in critically ill adult patients with sepsis. Int J Crit Illn Inj Sci. 2018; 8(3): 165–172.
     Google Scholar
  10. Economidou F, Douka E, Tzanela M, Nanas S, Kotanidou A. Thyroid function during critical illness. Hormones. 2011; 10(2): 117-24.
     Google Scholar
  11. Plikat K, Langgartner J, Buettner R, Bollheimer LC, Woenckhaus U, Schölmerich J, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism: Clinical and Experimental. 2007; 56(2): 239-44.
     Google Scholar
  12. Ataoğlu HE, Ahbab S, Serez MK, Yamak M, Kayaş D, Canbaz ET, et al. Prognostic significance of high free T4 and low free T3 levels in non-thyroidal illness syndrome. European Journal of Internal Medicine. 2018; 57: 91–95.
     Google Scholar
  13. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. The Journal of the American Medical Association. 2004; 292(21): 2591–9.
     Google Scholar
  14. Tognini S, Marchini F, Dardano A, Polini A, Ferdeghini M, Castiglioni M, et al. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age and Ageing. 2010; 39(1): 46–50.
     Google Scholar
  15. Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, et al. The cytokine storm and thyroid hormone changes in COVID 19. Journal of Endocrinological Investigation. 2021; 44: 891–904.
     Google Scholar
  16. Straub RH, Cutolo M. Glucocorticoids and chronic inflammation. Rheumatology. 2016; 55: ii6ii14.
     Google Scholar
  17. Ceresini G, Marina M, Lauretani F, Maggio M, Bandinelli S, Geda GP, et al. Relationship between circulating concentrations of thyrotropin, free thyroxine, and free triiodothyronine and 9-year mortality in euthyroid elderly subjects. Journal of the American Geriatric Society. 2016; 64(3): 553.
     Google Scholar
  18. Merke A, Merke J, Silbernagel G, März W. Free thyroid hormones and mortality in caucasians undergoing angiography: the Ludwigshafen risk and cardiovascular health (luric) study. Endocrine Practice. 2017; 23(3): 288-298.
     Google Scholar
  19. Moura Neto A, Zantut-Wittmann DE. Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings. International Journal of Endocrinology. 2016: 1–9.
     Google Scholar
  20. Borzio M, Caldara R, Borzio F, Piepoli V, Rampini P, Ferrari C. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. Gut. 1983; 24(7): 631–636.
     Google Scholar
  21. Xu G, Yan Y, Liu Y. The cardiovascular disease risks of nonthyroidal illness syndrome and inflammatory responses on patients with chronic kidney disease: from the association to clinical prognosis. Cardiovascular Therapeutics. 2014; 32(6): 257-63.
     Google Scholar